Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition
- PMID: 39082188
- DOI: 10.1093/cvr/cvae145
Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition
Conflict of interest statement
Conflict of interest: C.M.M. has received research grants to the institution from EliLilly, AstraZeneca, Roche, Amgen, Novartis, Novo Nordisk, and MSD, including speaker or consultant fees.
Comment on
-
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.Cardiovasc Res. 2024 Oct 14;120(12):1456-1471. doi: 10.1093/cvr/cvae144. Cardiovasc Res. 2024. PMID: 39001869 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
